Common 4q24 deletion in four cases of hematopoietic malignancy: Early stem cell involvement?

Leukemia

Volumn 19, Issue 8, 2005, Pages 1411-1415

  Viguié, Franck ^a   Aboura, A ^a   Bouscary, D ^b   Ramond, S ^a   Delmer, A ^a   Tachdjian, G ^c   Marie, J P ^a   Casadevall, N ^a  

^a HÔTEL DIEU   (France)

^b Hôpital Cochin ^*  (France)

^c HÔPITAL ANTOINE BÉCLÈRE   (France)

Author keywords

4q24 microdeletion; Acute myeloid leukemia; Hematopoietic stem cell; Lymphoma; Myelodysplastic syndrome

Indexed keywords

CD19 ANTIGEN; CD2 ANTIGEN; CD20 ANTIGEN; CD3 ANTIGEN; CD33 ANTIGEN; CD34 ANTIGEN; CD4 ANTIGEN; CD56 ANTIGEN; COMMON ACUTE LYMPHOBLASTIC LEUKEMIA ANTIGEN; CYCLOPHOSPHAMIDE; CYTARABINE; DAUNORUBICIN; DOXORUBICIN; ETOPOSIDE; IDARUBICIN; MICROSOMAL AMINOPEPTIDASE; MITOXANTRONE; PREDNISONE; STEM CELL FACTOR RECEPTOR; VINCRISTINE;

ACUTE GRANULOCYTIC LEUKEMIA; ADULT; ARTICLE; AUTOLOGOUS PERIPHERAL BLOOD STEM CELL TRANSPLANTATION; B CELL LYMPHOMA; B LYMPHOCYTE; BONE MARROW CELL; CASE REPORT; CHROMOSOME 3Q; CHROMOSOME 4Q; CHROMOSOME 5P; CHROMOSOME 7Q; CHROMOSOME ANALYSIS; CHROMOSOME DELETION 4; CHROMOSOME MOSAICISM; CHROMOSOME REARRANGEMENT; CHROMOSOME TRANSLOCATION 3; CHROMOSOME TRANSLOCATION 4; CHROMOSOME TRANSLOCATION 5; CHROMOSOME TRANSLOCATION 7; CLINICAL FEATURE; COMORBIDITY; DISEASE ASSOCIATION; DRUG MEGADOSE; FEMALE; FLUORESCENCE IN SITU HYBRIDIZATION; HEMATOPOIETIC STEM CELL; HUMAN; IMMUNOPHENOTYPING; KARYOTYPING; LEUKEMIA REMISSION; LYMPH NODE BIOPSY; LYMPHADENOPATHY; LYMPHOBLASTOID CELL LINE; LYMPHOMA CELL; MORTALITY; MYELODYSPLASIA; PRIORITY JOURNAL; SEPSIS; T LYMPHOCYTE; TREATMENT OUTCOME; TUMOR SUPPRESSOR GENE;

EID: 23744440061     PISSN: 08876924     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.leu.2403818     Document Type: Article

References (22)

1. Mitelman F, Johansson B, Mertens F. Mitelman database of chromosome aberrations in cancer 2001. http://cgap.nci.nih.gov/Chromosomes/Mitelman.
2. Mrozek K, Heerema NA, Bloomfield CD. Cytogenetics in acute leukemia. Blood Rev 2004; 18: 115-136.
3. Nilsson L, Astrand-Grundstrom I, Anderson K, Arvidsson I, Hokland P, Bryder D et al. Involvement and functional impairment of the CD34(+)CD38(-)Thy-1(+) hematopoietic stem cell pool in myelodysplastic syndromes with trisomy 8. Blood 2002; 100: 259-267.
4. Fialkow PJ, Singer JW, Adamson JW, Vaidya K, Dow LW, Ochs J et al. Acute nonlymphocytic leukemia: heterogeneity of stem cell origin. Blood 1981; 57: 1068-1073.
5. Ferraris AM, Broccia G, Meloni T, Canepa L, Sessarego M, Gaetani GF. Clonal origin of cells restricted to monocytic differentiation in acute nonlymphocytic leukemia. Blood 1984; 64: 817-820.
6. Heaney ML, Golde DW. Myelodysplasia. N Engl J Med 1999; 340: 1649-1660.
7. Janssen JW, Buschle M, Layton M, Drexler HG, Lyons J, van den Berghe H et al. Clonal analysis of myelodysplastic syndromes: evidence of multipotent stem cell origin. Blood 1989; 73: 248-254.
8. Tsukamoto N, Morita K, Maehara T, Okamoto K, Karasawa M, Omine M et al. Clonality in myelodysplastic syndromes: demonstration of pluripotent stem cell origin using X-linked restriction fragment length polymorphisms. Br J Haematol 1993; 83: 589-594.
9. Haase D, Feuring-Buske M, Konemann S, Fonatsch C, Troff C, Verbeek W et al. Evidence for malignant transformation in acute myeloid leukemia at the level of early hematopoietic stem cells by cytogenetic analysis of CD34+ subpopulations. Blood 1995; 86: 2906-2912.
10. Miyamoto T, Weissman IL, Akashi K. AML1/ETO-expressing nonleukemic stem cells in acute myelogenous leukaemia with 8;21 chromosomal translocation. Proc Natl Acad Sci USA 2000; 97: 7521-7526.
11. Mitelman F (ed). ISCN. An International System for Human Cytogenetic Nomenclature. Basel: S Karger, 1995.
12. Maserati E, Aprilui F, Vinante F, Locatelli F, Amendola G, Zatterale A et al. Trisomy 8 in myelodysplasia and acute leukemia is constitutional in 15-20% of cases. Genes Chromosomes Cancer 2002; 33: 93-97.
13. Bodmer D, Eleveld M, Kater-Baats E, Janssen I, Janssen B, Weterman M et al. Disruption of a novel MFS transporter gene, DIRC2, by a familial renal cell carcinoma-associated t(2;3)(q35;q21). Hum Mol Genet 2002; 11: 641-649.
14. Yeo W, Wong N, Chow J, Tsoi WC, Johnson PJ, Wickham N. Small cell variant of Ki-1 lymphoma associated with myelofibrosis and a novel constitutional chromosomal translocation t(3;4) (q13;q12). J Clin Pathol 1996; 49: 259-262.
15. Daibata M, Nemoto Y, Komatsu N, Machida H, Miyoshi I, Taguchi H. Constitutional t(3;11)(p21;q23) in a family, including one member with lymphoma: establishment of novel cell lines with this translocation. Cancer Genet Cytogenet 2000; 117: 28-31.
16. Kitamura E, Kuemerle BA, Chernova OB, Cowell JK. Molecular characterization of the breakpoint region associated with a constitutional t(2;15)(q34;q26) in a patient with multiple myeloma. Cancer Genet Cytogenet 2001; 129: 112-119.
17. Lafrate AJ, Feuk L, Rivera MN, Listewnik ML, Donahoe PK, Qi Y et al. Detection of large-scale variation in the human genome. Nat Genet 2004; 36: 949-951.
18. Sebat J, Lakshmi B, Troge J, Alexander J, Young J, Lundin P et al. Large-scale copy number polymorphism in the human genome. Science 2004; 305: 525-528.
19. Huntly BJ, Bench A, Green AR. Double jeopardy from a single translocation: deletions of the derivative chromosome 9 in chronic myeloid leukemia. Blood 2003; 102: 1160-1168.
20. Kolomietz E, Al-Maghrabi J, Brennan S, Karaskova J, Minkin S, Lipton J et al. Primary chromosomal rearrangements of leukemia are frequently accompanied by extensive submicroscopic deletions and may lead to altered prognosis. Blood 2001; 97: 3581-3588.
21. Christensen K, Kristiansen M, Hagen-Larsen H, Skytthe A, Bathum L, Jeune B et al. X-linked genetic factors regulate hematopoietic stem-cell kinetics in females. Blood 2000; 95: 2449-2451.
22. Cools J, Stover EH, Wlodarska I, Marynen P, Gilliland DG. The FIP1L1-PDGFRalpha kinase in hypereosinophilic syndrome and chronic eosinophilic leukemia. Curr Opin Hematol 2004; 11: 51-57.